NV-CTA
11.1.2020 01:52:11 CET | Business Wire | Press release
CES® 2020 wrapped today, following a week filled with over 20,000 product debuts unveiling the future of technology. More than 4,400 exhibiting companies launched their latest tech products to some 170,000 attendees across more than 2.9 million net square feet of exhibit space. From global tech brands to pioneering startups, the innovation at CES 2020 will revolutionize markets and change our world for the better.
“CES 2020 inspired and connected every major industry across the globe,” said Gary Shapiro, president and CEO of the Consumer Technology Association (CTA)TM , owner and producer of CES. “The innovation unveiled at CES 2020 will reshape industries, create jobs, fuel the global economy and improve lives around the world.”
“This week at CES illustrated that every company is truly a tech company,” said Karen Chupka, executive vice president, CES. “Global technology brands blended with non-traditional tech companies to showcase how innovation is furthering business across all markets – setting the stage for the decade ahead.”
Key Themes at CES
CES 2020 featured the entire spectrum of transformative technology that will redefine markets and shift business models, including:
Artificial Intelligence
- AI was dominant throughout the show floor and will be a ‘key ingredient technology’ over the next decade. Companies debuted their latest AI solutions, including Brunswick, Doosan, John Deere and Kyocera.
5G and Mobile Connectivity
- CES is the only show where the entire 5G ecosystem – the backbone for connectivity, transportation, augmented and virtual reality, digital health and more – comes together. Carriers and mobile operators, such as Verizon, Sprint, AT&T, Nokia and Ericsson , demonstrated the latest advancements in 5G’s speed, reliability and efficiency.
Non-Traditional Tech Companies at CES
- Non-traditional companies used CES 2020 as a platform to launch products. Impossible Foods returned to CES 2020, debuting its Impossible Pork; John Deere was featured in the AI & Robotics Marketplace and other companies, such as Bell, Delta Airlines, L’Oreal, NBCUniversal and Proctor & Gamble unveiled how they’re transforming their businesses through technology.
Tech for Good
- Innovative technologies launched at CES that will change lives and improve our world. Digital health technologies were a major theme, with advancements in digital therapeutics, wearables and remote patient monitoring as digital health addresses real world issues like opioid dependence, mental illness and chronic disease. The Health & Wellness category saw an increase of nearly 25% with more than 135 exhibiting companies at CES 2020, including Humetrix and InBody .
- The Smart Cities exhibit area expanded by nearly 25% over 2019, with companies and organizations including the Department of Transportation , Hitachi and Siemens , highlighting products that will revitalize economies and help communities survive and thrive.
- CTA also partnered with the World Bank Group at CES 2020 on a Global Tech Challenge , calling for companies around the world to create solutions focused on three key areas: health, gender inequality and technologies that enable communities to be resilient. The Health Tech Challenge category is accepting applications through February 25 to connect innovators with healthcare providers in East Africa.
Eureka Park
- CES 2020 was also the world’s largest startup event, with more than 1,200 companies from 46 countries featured within Eureka Park, offering disruptive innovations, attracting investors and big-name brands. Technologies unveiled within Eureka Park include the Oval Home smart sensor that analyzes temperature, light, humidity and movement in the home; Yoganotch , which applies motion capture technology to help users improve poses; and Caregiver Smart Solutions with sensors that track movement and patterns to provide caregivers reassurance and patients with more independence at home.
“CES has the unique ability for startups and young companies to get exposure to major global brands,” said Mara Lewis, Co-Founder and CEO, ID8 Innovation; member, CTA Board of Industry Leaders. “The opportunities for venture funding and growth are incredible here. And the CES 2020 Diversity and Inclusion conference track was mind blowing!”
Diversity and Inclusion
- CES 2020 had a large focus on Diversity and Inclusion, with new programming and partnerships. The Innovation for All conference program featured chief diversity officers and leaders from Bosch , HP and Walmart , and explored inclusive ways that D&I is contributing to the bottom line, shifting culture, hiring differently and investing in diversity.
Travel and Tourism
- Delta Airlines was the first airline to keynote at CES. During his address, Delta Air Lines CEO Ed Bastian described the future world of travel through tech, including AI, AR, biometric security, smart incentive programs, and a new Parallel Reality experience, as travel becomes more customized.
Transportation and Vehicle Technology
- CES 2020 was revved up highlighting the future of transportation. Nine of the world’s leading car manufacturers, including Audi , BMW , Daimler (Mercedes), FCA, Ford , Honda , Hyundai , Nissan and Toyota , and more than 150 vehicle tech exhibitors unveiled the latest in connected cars, self-driving vehicles and concept cars. Products included the Mercedes Vision AVTR concept car, Audi’s AI:ME and the Sony Vision S.
C Space
- CES brought together content creators, Hollywood, the advertising and music industries, media and leading CMOs to explore the future of brand marketing and entertainment, including streaming services, through the return of C Space. The 2020 program featured more than 60 exhibitors, including AT&T Services, Comcast, Google, HP, Hulu, iHeart, NBC Universal, Pandora, Reddit, Roku, SiriuXM, Snap, Twitch, Turner, Univision and WWE.
Keynotes
The CES stage featured more than 1,100 speakers representing major global industries, including keynotes from Samsung President and CEO of Consumer Electronics Division Mr. Hyun-Suk Kim ; Daimler Chairman Ola Källenius ; Delta Air Lines CEO Ed Bastian ; NBCUniversal Chairman of Advertising and Partnerships Linda Yaccarino ; Quibi CEO Meg Whitman and Founder Jeffrey Katzenberg ; U.S. Secretary of Transportation Elaine L. Chao ; Salesforce Chairman and co-CEO Marc Benioff ; Unilever CEO Alan Jope ; and Presidential Advisor, Ivanka Trump .
Visit CES.tech/Live to see the CES keynotes, SuperSessions and other conference programs.
“We hosted 40 CEOs and corporate directors here, and over half were attending CES for the very first time,” said Nichole Jordan, Central Region Managing Partner, Grant Thornton; member, CTA Board of Industry Leaders. “As we debriefed, they said this show – this experience – helps them to reimagine their businesses and their futures.”
CES, the world’s largest and most influential tech event, returns to Las Vegas, January 6-9, 2021. Visit CES.tech for product announcements , keynote and session videos, b-roll footage and more.
About CES:
CES® is the largest, most influential tech event in the world – the proving ground for breakthrough technologies and global innovators. This is where the world's biggest brands do business and meet new partners, and the sharpest innovators hit the stage. Owned and produced by the Consumer Technology Association (CTA)® , CES features every aspect of the tech sector. Learn more at CES.tech and follow CES on social .
About Consumer Technology Association:
As North America’s largest technology trade association, CTA® is the tech sector. Our members are the world’s leading innovators – from startups to global brands – helping support more than 18 million American jobs. CTA owns and produces CES® – the largest, most influential tech event in the world. Find us at CTA.tech . Follow us @CTAtech
UPCOMING EVENTS
-
CES 2021
January 6-9, 2021 – Las Vegas, NV
View source version on businesswire.com: https://www.businesswire.com/news/home/20200110005584/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
